We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$10.7B
AUM Growth
-$1.2B
Cap. Flow
-$1.77B
Cap. Flow %
-16.59%
Top 10 Hldgs %
17.61%
Holding
1,734
New
553
Increased
270
Reduced
235
Closed
408

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$107M
2
STX icon
Seagate
STX
+$46.6M
3
ROP icon
Roper Technologies
ROP
+$46.2M
4
INTC icon
Intel
INTC
+$44.7M
5
NTNX icon
Nutanix
NTNX
+$42.7M

Sector Composition

Rank Sector Weight
1 Technology 10.53%
2 Financials 5.9%
3 Healthcare 3.32%
4 Energy 2.62%
5 Communication Services 2.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKYH.WS icon
651
Sky Harbour Group Warrants
SKYH.WS
$17.4M
$1.59M 0.01%
516,471
MNSO icon
652
MINISO
MNSO
$3.73B
$1.58M 0.01%
85,603
-23,736
-22% -$518K
WIT icon
653
Wipro
WIT
$19B
$1.58M 0.01%
516,180
-741,951
-59% -$2.53M
ZTO icon
654
ZTO Express
ZTO
$18.2B
$1.58M 0.01%
79,485
-149,865
-65% -$2.92M
EIX icon
655
CALL
Edison International
EIX
$30.7B
$1.57M 0.01%
+26,600
New +$1.53M
ALNY icon
656
PUT
Alnylam Pharmaceuticals
ALNY
$38.5B
$1.57M 0.01%
+5,800
New +$1.49M
GILD icon
657
Gilead Sciences
GILD
$167B
$1.56M 0.01%
13,922
-42,877
-75% -$4.42M
JCI icon
658
CALL
Johnson Controls International
JCI
$85.6B
$1.55M 0.01%
+19,300
New +$1.59M
UTHR icon
659
PUT
United Therapeutics
UTHR
$26.1B
$1.54M 0.01%
5,000
-5,000
-50% -$1.71M
PODD icon
660
Insulet
PODD
$11.6B
$1.53M 0.01%
5,845
+690
+13% +$187K
EVRG icon
661
Evergy
EVRG
$19.7B
$1.53M 0.01%
22,159
+21,627
+4,065% +$1.42M
PLTR icon
662
Palantir
PLTR
$296B
$1.52M 0.01%
18,000
-6,909
-28% -$607K
CRDO icon
663
Credo Technology Group
CRDO
$35.9B
$1.51M 0.01%
37,680
+1,745
+5% +$108K
SNDK
664
Sandisk
SNDK
$162B
$1.51M 0.01%
+31,671
New +$1.57M
SU icon
665
PUT
Suncor Energy
SU
$75.4B
$1.48M 0.01%
+38,300
New +$1.46M
THC icon
666
Tenet Healthcare
THC
$22.6B
$1.48M 0.01%
11,018
+4,201
+62% +$553K
SGRY icon
667
Surgery Partners
SGRY
$2.04B
$1.48M 0.01%
62,298
-39,502
-39% -$935K
LQDA icon
668
PUT
Liquidia Corp
LQDA
$7.72B
$1.48M 0.01%
+100,000
New +$1.46M
RNW icon
669
ReNew
RNW
$2.22B
$1.47M 0.01%
+250,000
New +$1.61M
HSY icon
670
Hershey
HSY
$37.2B
$1.46M 0.01%
+8,525
New +$1.4M
HLT icon
671
PUT
Hilton Worldwide
HLT
$72.6B
$1.46M 0.01%
+6,400
New +$1.59M
CZR icon
672
Caesars Entertainment
CZR
$6.1B
$1.44M 0.01%
57,589
+9,047
+19% +$294K
EXAS
673
CALL
DELISTED
Exact Sciences
EXAS
$1.44M 0.01%
33,200
-36,800
-53% -$1.86M
UNH icon
674
CALL
UnitedHealth
UNH
$389B
$1.41M 0.01%
2,700
-6,300
-70% -$3.22M
NCLH icon
675
Norwegian Cruise Line
NCLH
$9.74B
$1.41M 0.01%
+74,513
New +$1.79M

Similar funds

LMR Partners's Q1 2025 Portfolio in Review

As of Q1 2025, LMR Partners held 1,734 positions worth $10.7B, down 10% from $11.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

LMR Partners withdrew a net $1.77B in Q1 2025, closing 408 positions and reducing 235 holdings. Its most notable exit was Endeavor Group Holdings, Inc., an estimated $204M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, LMR Partners opened a new position in Roper Technologies worth $48.6M.

  • LMR Partners's largest Q1 2025 buy was Roper Technologies: 82,349 shares worth $48.6M.
  • LMR Partners added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $107M increase.
  • LMR Partners's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $469M.
  • LMR Partners fully exited Endeavor Group Holdings, Inc. in Q1 2025, selling an estimated $204M.
  • LMR Partners's ten largest holdings make up 18% of its $10.7B portfolio in Q1 2025.
  • LMR Partners opened 553 new positions and closed 408 in Q1 2025.
  • LMR Partners's portfolio value fell 10% quarter-over-quarter to $10.7B.

Based on LMR Partners's 13F filing for Q1 2025, filed 15 May 2025.